Skip to main content

Advertisement

Fig. 6 | Clinical Proteomics

Fig. 6

From: Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fig. 6

Validation of protein fragment by Western blot analyses. a Expression levels of the fibrinogen alpha chain and dihydropyrimidinase-like 2 differ among the four groups of HC, MM-ND, and MM-RR. PF4 immunoreactive bands show that weak or no band was detected in ND and RR MM cases. b Densitometry comparison of PF4 protein relative to β-actin as determined by Western blot analyses in (a). c Densitometry comparison of dihydropyrimidinase-like 2 protein relative to β-actin as determined by Western blot analyses in (a). d Densitometry comparison of fibrinogen alpha chain protein relative to β-actin as determined by Western blot analyses in (a)

Back to article page